MBX Biosciences (MBX) Prepaid Assets (2023 - 2026)
MBX Biosciences' (MBX) quarterly Prepaid Assets came in at $8.6 million in Q1 2026, up 1267.25% year-on-year from $626000.0 in Q1 2025, and up 9.25% quarter-over-quarter from $7.8 million in Q4 2025.
MBX Biosciences (MBX) Prepaid Assets (2023 - 2026) Analysis & Trends
MBX Biosciences has disclosed Prepaid Assets across 4 years of filings, most recently posting $8.6 million for Q1 2026.
- Prepaid Assets for Q1 2026 came in at $8.6 million, up 1267.25% year-over-year; the trailing twelve-month figure through Mar 2026 was $8.6 million (up 1267.25% YoY), and the FY2025 annual result was $7.8 million, up 52.5% from the prior year.
- Prepaid Assets came in at $8.6 million for Q1 2026 at MBX Biosciences, up from $7.8 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $8.6 million in Q1 2026 to a low of $133000.0 in Q4 2023.
- The 4-year median for Prepaid Assets is $860000.0 (2024), against an average of $3.1 million.
- Across the five-year window, Prepaid Assets soared 3762.41% in 2024 and advanced 5.25% in 2025, its largest moves.
- MBX Biosciences' Prepaid Assets stood at $133000.0 in 2023, then jumped by 3762.41% to $5.1 million in 2024, then soared by 52.5% to $7.8 million in 2025, then gained by 9.25% to $8.6 million in 2026.
- The last three Prepaid Assets figures came in at $8.6 million (Q1 2026), $7.8 million (Q4 2025), and $882000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | MBX Biosciences | 1.44 Bn | 1.44 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.56 Mn |
| Dec 31, 2025 | 7.83 Mn |
| Sep 30, 2025 | 882,000.00 |
| Jun 30, 2025 | 472,000.00 |
| Mar 31, 2025 | 626,000.00 |
| Dec 31, 2024 | 5.14 Mn |
| Sep 30, 2024 | 838,000.00 |
| Dec 31, 2023 | 133,000.00 |